Namodenoson 25mg

Drug identity checked against registry records

Also recorded as CF102

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Namodenoson Treatment of Advanced Pancreatic CancerNCT06387342Can-Fite BioPharmaPhase 2Recruiting2026-07-15Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.